A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Standard Care to Treat Vision Loss Associated With Macular Edema Secondary to Branch Retinal Vein Occlusion
Top Cited Papers
- 14 September 2009
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Ophthalmology
- Vol. 127 (9), 1115-1128
- https://doi.org/10.1001/archophthalmol.2009.233
Abstract
To compare the efficacy and safety of 1-mg and 4-mg doses of preservative-free intravitreal triamcinolone with standard care (grid photocoagulation in eyes without dense macular hemorrhage and deferral of photocoagulation until hemorrhage clears in eyes with dense macular hemorrhage) for eyes with vision loss associated with macular edema secondary to branch retinal vein occlusion (BRVO). Multicenter, randomized clinical trial of 411 participants. Gain in visual acuity letter score of 15 or more from baseline to month 12. Twenty-nine percent, 26%, and 27% of participants achieved the primary outcome in the standard care, 1-mg, and 4-mg groups, respectively. None of the pairwise comparisons between the 3 groups was statistically significant at month 12. The rates of elevated intraocular pressure and cataract were similar for the standard care and 1-mg groups, but higher in the 4-mg group. There was no difference identified in visual acuity at 12 months for the standard care group compared with the triamcinolone groups; however, rates of adverse events (particularly elevated intraocular pressure and cataract) were highest in the 4-mg group. Grid photocoagulation as applied in the SCORE Study remains the standard care for patients with vision loss associated with macular edema secondary to BRVO who have characteristics similar to participants in the SCORE-BRVO trial. Grid photocoagulation should remain the benchmark against which other treatments are compared in clinical trials for eyes with vision loss associated with macular edema secondary to BRVO. clinicaltrials.gov Identifier: NCT00105027Keywords
This publication has 54 references indexed in Scilit:
- Problems with Attempted Chorioretinal Venous Anastomosis by Laser for Nonischemic CRVO and BRVOOphthalmologica, 2005
- Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot studyActa Ophthalmologica Scandinavica, 2005
- INTRAVITREAL TRIAMCINOLONE AS PRIMARY TREATMENT OF CYSTOID MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSIONRetina, 2005
- Intravitreal Versus Retrobulbar Injections of Triamcinolone for Macular Edema Associated With Branch Retinal Vein OcclusionAmerican Journal of Ophthalmology, 2005
- New Therapy for Central Retinal Vein OcclusionAmerican Journal of Ophthalmology, 2005
- Intravitreal Triamcinolone Acetonide for Macular Edema Associated With Diabetic Retinopathy and Venous Occlusive DiseaseAmerican Journal of Ophthalmology, 2005
- Presumed Sterile Endophthalmitis Following Intravitreal Triamcinolone Acetonide InjectionOphthalmic Surgery, Lasers and Imaging Retina, 2005
- Early Treatment of Cystoid Macular Edema Secondary to Branch Retinal Vein Occlusion With Intravitreal Triamcinolone AcetonideOphthalmic Surgery, Lasers and Imaging Retina, 2005
- The Efficacy of Intravitreal Triamcinolone Acetonide on Macular Edema in Branch Retinal Vein OcclusionEuropean Journal of Ophthalmology, 2005
- Branch retinal vein occlusion treated by intravitreal triamcinolone acetonideEye, 2004